Cognitive-behavioral therapy for HIV medication adherence and depression

Cognitive and Behavioral Practice

Volumn 11, Issue 4, 2004, Pages 415-424

  Safren, Steven A ^a,d   Hendriksen, Ellen S ^b   Mayer, Kenneth H ^c   Mimiaga, Matthew J ^b   Pickard, Robert ^b   Otto, Michael W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Fenway Community Health   (United States)

^c BROWN UNIVERSITY   (United States)

^d Research and Evaluation Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; BREATHING EXERCISE; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBLEM SOLVING; SELF CARE; SEXUAL TRANSMISSION;

EID: 32444441284     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(04)80058-0     Document Type: Article

References (52)

1. Agency for Health Care Policy and Research. Depression Guideline Panel. Clinical Practice Guideline Number 5. (1993a). Depression in Primary Care: Volume 2. Treatment of Major Depression. (AHCPR Publication No. 93-0551). Rockville, MD: U.S. Dept. of Health and Human Services.
2. Agency for Health Care Policy and Research. Depression Guideline Panel. Clinical Practice Guideline Number 5. (1993b). Depression in Primary Care: Volume I. Detection and diagnosis (AHCPR Publication No. 93-0550). Rockville, MD: U.S. Dept. of Health and Human Services.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Atkinson, J. H., & Grant, I. (1994). Natural history of neuropsychiatric manifestations of HIV disease. Psychiatric Clinics of North America, 17, 17-33.
5. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 14, 357-66.
6. Beck, A. (1987). Cognitive therapy of depression. New York: The Guilford Press.
7. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
8. Beck, J., & Beck, A. (1995). Cognitive therapy. New York: The Guilford Press.
9. Besch, C. L. (1995). Compliance in clinical trials. AIDS. 9, 1-10.
10. Carpenter, C. C., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., & Volberding, P. A. (2000). Antiretroviral therapy in adults: Updated recommendations from the International AIDS Society-USA Panel. Journal of the American Medical Association, 283, 381-390.
11. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
12. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & Patient Care Committee and Adherence Working Group of the Adult AIDS Clinical Trials Group. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.
13. Cotanch, P. H. (1983). Relaxation training for control of nausea and vomiting in patients receiving chemotherapy. Cancer Nursing, 6, 277-283
14. Dew, M. A., Becker, J. T., Sanchez, J., Cladararo, R., Lopez, O. L., Wess, J., Dorst, S. K., & Banks, G. (1997). Prevalence and predictors of depressive, anxiety, and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological Medicine, 27, 395-409.
15. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107.
16. D'Zurilla, T. J. (1986). Problem solving therapy: A social competence approach to clinical interventions. New York: Springer.
17. Evans, D. L., Ten Have, T. R., Douglas, S. D., Gettes, D. R., Morrison, M., Chiappini, M. S., Briuker-Spence, P., Job, C., Mercer, D. E., Wang, Y. L., Cruess, D., Dube, B., Dalen, E. A., Brown, T., Bauer, R., & Petitto, J. M. (2002). Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. The American Journal of Psychiatry, 159, 1752-1759.
18. Evans, M. D., Hollon, S. D., DeRubeis, R. J., Piasecki, J. M., Grove, W. M., Garvey, M. J., & Tuason, V. B. (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 155, 1443-1445.
19. Fava, M., Alpert, J. E., Nierenberg, A. A., Worthington, J. J., & Rosenbaum, J. F. (2000). Double-blind study of high dose fluoxetine versus lithium or desipramine agumentation of fluoxetine in partial and nonresponders to fluoxetine. Paper presented at the annual meeting of the American Psychiatric Association, Chicago.
20. Fara, M., & Davidson, K. G. (1996). Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America, 19, 179-2000.
21. First, M., Spitzer, R. L., Gibbon, M., & Williams, J. (1995). Structured clinical interview for DSM-IV Axis I disorders, patient edition. Biometrics Research Department, New York State Psychiatric Institute. New York, NY.
22. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386-395.
23. Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy, AIDS, 13, 1763-1769.
24. Hamilton, M. (1959). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62.
25. Hecht, F. M., Colfax, G., Swanson, M., & Chesney, M. A. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago.
26. Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., Inouye, J., Henry, S. B., Nicholas, P. K., & Portillo, C. J. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care & STDS, 13, 185-197.
27. Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385-391.
28. Kalichman, S. C., Ramachandran, B., & Ostrow, D. (1998). Protease inhibitors and the new AIDS combination therapies: Implications for psychological scnices. Professional Psychology: Research and Practice, 29, 349-356.
29. Kelly, J. A., Otto-Salaj, L. L., Sikkema, K. J., Pinkerton, S. D., & Bloom, F. R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310-319.
30. Lyketsos, C. G., Hanson, A. L., Fishman, M., McHugh, P. R., & Treisman, G. J. (1994). Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: The need for a psychiatric presence. International Journal of Psychiatry and Medicine, 24, 103-113.
31. Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior: New York: The Guilford Press.
32. Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Weinberg, M. A., Smith, D., Robinson, P., Hall, D., Myers, M., & Lange, J. M. A. (1998). A randomized, double-blind trial comparing combinations of nevarpine, didanosine, and zidovudine for HIV-infected patients. JAMA, 279, 930-937.
33. National Institute of Mental Health. (1985). CGI: Clinical Global Impression Scale - NIMH. Psychopharmacology Bulletin, 21, 839-844.
34. Nezu, A. M., Nezu, C. M., Friedman, S. H., Faddis, S., & Houts, P. S. (1998). Helping cancer patients cope: A problem-solving approach. Washington, DC: American Psychological Association.
35. Nezu, A. M., Nezu, C. M., Friedman, S. H., Houts, P. S., & Faddis, S. (1997). Project Genesis: Application of problem-solving therapy to individuals with cancer. the Behavior Therapist, 9, 155-158.
36. Nezu, A. M., & Perri, M. G. (1989). Social problem-solving therapy for unipolar depression: An initial dismantling investigation. Journal of Consulting and Clinical Psychology, 57, 408-413.
37. Ouken, L. S., Blaine, J. D., & Battjes, R. (1997). Behavioral therapy research: A conceptualization of a process. In S. W. Henngler & R. Amentos (Ed.). Innovative approaches from difficult to treat populations (pp. 477-485). Washington,DC: American Psychiatric Press.
38. Paterson, D. L., Swindells, S., Mohr, J., Vergis, E. N., Squire, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
39. Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Mechan, M. O., Lutalo, T., & Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type I. Rakai Project Study Group. New England Journal of Medicine, 342, 921-929.
40. Rabkin, J. G. (1996). Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry, 8, 157-166.
41. Rounsaville, B. J., Carroll, K. M., & Ouken, L. S. (2001). A stage model of behavioral therapies research: Getting started and moving on from stage I. Clinical Psychology Science Practice, 8, 133-142.
42. Safren, S. A., Hendriksen, E. S., DeSousa, N., Boswell, S., & Mayer, K. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15, 787-793.
43. Safren, S. A., Otto, M. W., & Worth, J. (1999). Life-Steps: Applying cognitive-behavioral therapy to patient adherence 10 HIV medication treatment. Cognitive and Behavioral Practice, 6, 332-341.
44. Safren, S. A., Otto, M. W., Worth, J., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-Steps and medication monitoring. Behavioural Reasearch and Therapy, 39, 11151-1162.
45. Safren, S. A., Radomsky, A. S., Otto, M. W. & Salomon, E. (2002). Predictors of psychological well-being in a diverse sample of HIV-positive patients on highly active antiretroviral therapy. Psychosomatics, 43, 478-485.
46. Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Cure, 10, 1033-1039.
47. Smith, W. B. (1987). Biofeedback and relaxation training: The effect on headache and associated symptoms. Headache, 27, 511-514.
48. Stansell, J., Holtzer, C., Mayer, S., DeGuzman, D., Hamel, E., & Lapins, D. (2001). Factors affecting treatment outcomes in a medication event monitoring system. Presented at the Eighth Conference on Retroviruses and Opportunistic Infections, Chicago.
49. Thomason, B., Bachanas, P. J., & Campos, P. E. (1996). Cognitive behavioral interventions with persons affected by HIV/AIDS. Cognitive and Behavioral Practice, 3, 417-442.
50. Turner, J. A., & Chapman, C. R. (1982). Psychological interventions for chronic pain: A critical review. Relaxation and biofeedback. Pain, 12, 1-21.
51. Williams, J. B. (1988). A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry, 45, 742-747.
52. Young, P. R., Grant, P., & DeRubeis, R. J. (2003). Some lessons from the group supervision of cognitive therapy for depression. Cognitive and Behavioral Practice, 10, 30-40.